Darunavir Tablets

Darunavir Tablets
SPL v1
SPL
SPL Set ID 6a029063-b14c-4eee-9958-0d9eecb27726
Route
ORAL
Published
Effective Date 2024-04-29
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Darunavir (600 mg)
Inactive Ingredients
Ferric Oxide Red Ferric Oxide Yellow Ferrosoferric Oxide Hydroxypropyl Cellulose, Unspecified Hypromellose 2910 (6 Mpa.s) Magnesium Stearate Microcrystalline Cellulose Silicon Dioxide Sodium Starch Glycolate Type A Potato Talc Titanium Dioxide

Identifiers & Packaging

Pill Appearance
Imprint: 1217 Shape: oval Color: brown Color: yellow Size: 20 mm Size: 21 mm Score: 1
Marketing Status
ANDA Active Since 2024-05-01

Description

NDC 70771-1745-6 Darunavir tablets, 600 mg 60 Tablets Rx only NDC 70771-1746-3 Darunavir tablets, 800 mg 30 Tablets Rx only


Medication Information

Description

NDC 70771-1745-6 Darunavir tablets, 600 mg 60 Tablets Rx only NDC 70771-1746-3 Darunavir tablets, 800 mg 30 Tablets Rx only

Package Label.principal Display Panel

NDC 70771-1745-6

Darunavir tablets, 600 mg

60 Tablets

Rx only

NDC 70771-1746-3

Darunavir tablets, 800 mg

30 Tablets

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1745-6

Darunavir tablets, 600 mg

60 Tablets

Rx only

NDC 70771-1746-3

Darunavir tablets, 800 mg

30 Tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)